Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation

References

• Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363–13383. doi:10.1073/pnas.95.23.133639811807
   PubMed Web of Science ®Google Scholar
• Rabinovici GD, Wang PN, Levin J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;66:286–287. doi:10.1212/01.wnl.0000196440.00297.6716434680
   PubMed Web of Science ®Google Scholar
• Heinemann U, Krasnianski A, Meissner B, Grasbon-Frodl EM, Kretzschmar HA, Zerr I. Novel PRNP mutation in a patient with a slow progressive dementia syndrome. Med Sci Monit. 2008;14:CS41–CS43.18443555
   PubMed Web of Science ®Google Scholar
• Kovács GG 1, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD experience. Human Genet. 2005;118:166–174. doi:10.1007/s00439-005-0020-116187142
   PubMed Web of Science ®Google Scholar
• Schmitz M, Dittmar K, Llorens F, et al. Hereditary human prion diseases: an update. MolNeurobiol. 2017;54:4138–4149. doi:10.1007/s12035-016-9918-y
   Google Scholar
• Bagyinszky E, Giau VV, Youn YC, An SSA, Kim S. Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases. Neuropsychiatr Dis Treat. 2018;14:2067–2085. doi:10.2147/NDT.S16544530147320
   PubMed Web of Science ®Google Scholar
• Castellani RJ, Perry G, Smith MA. Prion disease and Alzheimer’s disease: pathogenic overlap. Acta Neurobiol Exp (Wars). 2004;64:11–17.15190676
   PubMed Web of Science ®Google Scholar
• Tousseyn T, Bajsarowicz K, Sánchez H, et al. Prion disease induces alzheimer disease-like neuropathologic changes. JNeuropatholExpNeurol. 2015;74:873–888. doi:10.1097/NEN.0000000000000228
   Web of Science ®Google Scholar
• Lee SM, Chung M, Hyeon JW, et al. Genomic characteristics of genetic creutzfeldt-jakob disease patients with V180I mutation and associations with other neurodegenerative disorders. Plos One. 2016;11:e0157540. doi:10.1371/journal.pone.015754027341347
   PubMed Web of Science ®Google Scholar
• Kallberg M, Wang H, Wang S, et al. Template-based protein structure modeling using the RaptorX web server. Nat Protoc. 2012;7:1511–1522. doi:10.1038/nprot.2012.08522814390
   PubMed Web of Science ®Google Scholar
• Bindea G, Mlecnik B, Hackl H, et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics. 2009;25:1091–1093. doi:10.1093/bioinformatics/btp10119237447
   PubMed Web of Science ®Google Scholar
• Jin K, Shiga Y, Shibuya S, et al. Clinical features of Creutzfeldt-Jakob disease with V180I mutation. Neurology. 2004;62:502–505. doi:10.1212/01.wnl.0000106954.54011.8014872044
   PubMed Web of Science ®Google Scholar
• Kim J, Lee D-S, Park KW. Familial creutzfeldt-jakob disease with V180I mutation presented with broca’s aphasia. J Korean Neurol Assoc. 2018;36:345–349. doi:10.17340/jkna.2018.4.15
   Google Scholar
• Yang TI, Jung DS, Ahn BY, et al. Familial Creutzfeldt-Jakob disease with V180I mutation. J Korean Med Sci. 2010;25:1097–1100. doi:10.3346/jkms.2010.25.7.109720592908
   PubMed Web of Science ®Google Scholar
• Paterson RW, Slattery CF, Poole T, et al. Cerebrospinal fluid in the differential diagnosis of alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic. Alzheimers Res Ther. 2018;10(1):32. doi:10.1186/s13195-018-0361-329558979
   PubMed Web of Science ®Google Scholar
• Moe Lee S, Ju Y R, Choi BY, et al. Genotype patterns and characteristics of PRNP in the Korean population. Prion. 2012;6:375–382. doi:10.4161/pri.2019522561193
   PubMed Web of Science ®Google Scholar
• Zhang W, Jiao B, Xiao T, et al. Mutational analysis of PRNP in Alzheimer’s disease and frontotemporal dementia in China. Sci Rep. 2016;6:38435. doi:10.1038/srep3843527910931
   PubMed Web of Science ®Google Scholar
• Kitamoto T, Iizuka R, Tateishi J. An amber mutation of prion protein in gerstmann-sträussler syndrome with mutant PrP plaques. Biochem Biophys Res Commun. 1993;192:525–531. doi:10.1006/bbrc.1993.14478097911
   PubMed Web of Science ®Google Scholar
• Jayadev S, Nochlin D, Poorkaj P, et al. Familial prion disease with Alzheimer disease-like tau pathology and clinical phenotype. Ann Neurol. 2011;69(4):712–720. doi:10.1002/ana.2226421416485
   PubMed Web of Science ®Google Scholar
• Mead S, Gandhi S, Beck J, et al. A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med. 2013;369:1904–1914. doi:10.1056/NEJMoa121474724224623
   PubMed Web of Science ®Google Scholar
• Muñoz-Nieto M, Ramonet N, López-Gastón JI, et al. A novel mutation I215V in the PRNP gene associated with creutzfeldt-jakob and Alzheimer’s diseases in three patients with divergent clinical phenotypes. J Neurol. 2013;260:77–84. doi:10.1007/s00415-012-6683-322763467
   PubMed Web of Science ®Google Scholar
• Minikel EV, Vallabh SM, Lek M, et al. Quantifying prion disease penetrance using large population control cohorts. Sci Transl Med. 2016;8:322ra9. doi:10.1126/scitranslmed.aaf0746
   PubMed Web of Science ®Google Scholar
• Yoshida H, Terada S, Ishizu H, et al. An autopsy case of creutzfeldt-jakob disease with a V180I mutation of the PrP gene and alzheimer-type pathology. Neuropathology. 2010;30:159–164. doi:10.1111/j.1440-1789.2009.01048.x19703264
   PubMed Web of Science ®Google Scholar
• Qina T, Sanjo N, Hizume M, et al. Clinical features of genetic creutzfeldt-jakob disease with V180I mutation in the prion protein gene. BMJ Open. 2014;4:e004968. doi:10.1136/bmjopen-2014-004968
   PubMed Web of Science ®Google Scholar
• Vardarajan BN, Zhang Y, Lee JH, et al. Coding mutations in SORL1 and alzheimer disease. Ann Neurol. 2015;77(2):215–227. doi:10.1002/ana.2430525382023
   PubMed Web of Science ®Google Scholar
• Aikawa T, Holm ML, Kanekiyo T. ABCA7 and pathogenic pathways of alzheimer’s disease. Brain Sci. 2018;8:pii: E27. doi:10.3390/brainsci8020027
   Web of Science ®Google Scholar
• Cuccaro ML, Carney RM, Zhang Y, et al. SORL1 mutations in early- and late-onset alzheimer disease. Neurol Genet. 2016;2(6):e116. doi:10.1212/NXG.000000000000011627822510
   PubMed Web of Science ®Google Scholar
• Gustafsen C, Glerup S, Pallesen LT, et al. Sortilin and SorLA display distinct roles in processing and trafficking of amyloid precursor protein. J Neurosci. 2013;33(1):64–71. doi:10.1523/JNEUROSCI.2371-12.201323283322
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Uchiyama K. Novel amplification mechanism of prions through disrupting sortilin-mediated trafficking. Prion. 2017;11(6):398–404. doi:10.1080/19336896.2017.139143529099278
   PubMed Web of Science ®Google Scholar
• Uchiyama K, Tomita M, Yano M, et al. Prions amplify through degradation of the VPS10P sorting receptor sortilin. PLoS Pathog. 2017;13(6):e1006470. doi:10.1371/journal.ppat.100647028665987
   PubMed Web of Science ®Google Scholar
• Fu Y, Hsiao JH, Paxinos G, Halliday GM, Kim WS. ABCA7 mediates phagocytic clearance of amyloid-β in the brain. J Alzheimers Dis. 2016;54(2):569–584. doi:10.3233/JAD-16045627472885
   PubMed Web of Science ®Google Scholar
• Carroll JA, Race B, Williams K, Striebel J, Chesebro B. Microglia are critical in host defense against prion disease. J Virol. 2018;92(15):pii: e00549-18. doi:10.1128/JVI.00549-18
   Web of Science ®Google Scholar
• Carroll JA 1, Chesebro B. Neuroinflammation, microglia, and cell-association during prion disease. Viruses. 2019;11(1):pii: E65. doi:10.3390/v11010065
   Web of Science ®Google Scholar
• Griffiths HH, Whitehouse IJ, Hooper NM. Regulation of amyloid-β production by the prion protein. Prion. 2012;6:217–222. doi:10.4161/pri.1898822449984
   PubMed Web of Science ®Google Scholar